The fragile benefit of BENEFIT.
Coles
Alasdair
A
D002986:Clinical Trials as Topic / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000191:economics* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy
D000068576:Interferon beta-1b; D016899:Interferon-beta